Point72 Middle East FZE »

Amylyx Pharmaceuticals shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $135k 9.1k 14.72
2023-09-30 $428k 23k 18.31
2023-06-30 $486k 23k 21.57

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals